Eldesouky, L.M.; El-Moslemany, R.M.; Ramadan, A.A.; Morsi, M.H.; Khalafallah, N.M.
Cyclosporine Lipid Nanocapsules as Thermoresponsive Gel for Dry Eye Management: Promising Corneal Mucoadhesion, Biodistribution and Preclinical Efficacy in Rabbits. Pharmaceutics 2021, 13, 360.
https://doi.org/10.3390/pharmaceutics13030360
AMA Style
Eldesouky LM, El-Moslemany RM, Ramadan AA, Morsi MH, Khalafallah NM.
Cyclosporine Lipid Nanocapsules as Thermoresponsive Gel for Dry Eye Management: Promising Corneal Mucoadhesion, Biodistribution and Preclinical Efficacy in Rabbits. Pharmaceutics. 2021; 13(3):360.
https://doi.org/10.3390/pharmaceutics13030360
Chicago/Turabian Style
Eldesouky, Lubna M., Riham M. El-Moslemany, Alyaa A. Ramadan, Mahmoud H. Morsi, and Nawal M. Khalafallah.
2021. "Cyclosporine Lipid Nanocapsules as Thermoresponsive Gel for Dry Eye Management: Promising Corneal Mucoadhesion, Biodistribution and Preclinical Efficacy in Rabbits" Pharmaceutics 13, no. 3: 360.
https://doi.org/10.3390/pharmaceutics13030360
APA Style
Eldesouky, L. M., El-Moslemany, R. M., Ramadan, A. A., Morsi, M. H., & Khalafallah, N. M.
(2021). Cyclosporine Lipid Nanocapsules as Thermoresponsive Gel for Dry Eye Management: Promising Corneal Mucoadhesion, Biodistribution and Preclinical Efficacy in Rabbits. Pharmaceutics, 13(3), 360.
https://doi.org/10.3390/pharmaceutics13030360